Search In this Thesis
   Search In this Thesis  
العنوان
Intravenous Fluid Supplementation as Treatment Modality in Severe Non-Hemolytic Neonatal Hyperbilirubinemia /
المؤلف
Ahmed, Boushra Youssef Mohamed.
هيئة الاعداد
باحث / بشزي يوسف محمد احمد
مشرف / فادي محمد الجندي
مشرف / حنان مصطفي محمد السيد
مشرف / أحمد شوقي أبوهوله
الموضوع
Pediatrics. Hyperbilirubinemia Neonatal. Jaundice Neonatal.
تاريخ النشر
2023.
عدد الصفحات
115 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
طب الأطفال ، الفترة المحيطة بالولادة وصحة الطفل
الناشر
تاريخ الإجازة
31/8/2023
مكان الإجازة
جامعة المنوفية - كلية الطب - طب الأطفال
الفهرس
Only 14 pages are availabe for public view

from 128

from 128

Abstract

Neonatal hyperbilirubinemia is a common clinical problem encountered during the neonatal period, especially in the first week of life. 60 to 80 % of healthy infants are expected to present with idiopathic neonatal jaundice However, may not appear jaundiced until the serum total bilirubin concentration exceeds 5.0 to 7.0 mg/dL.
The study aimed to find out the effect of breastfeeding on demand or formula feeding with extra IV fluid supplementation was given for a period of 8 h. The volume of IV fluid supplementation included half of their daily maintenance requirement for 8-h period and a phototherapy allowance of 20 ml ⁄ kg ⁄ day for 8 h. the type of fluid used was 0.9% saline in 5% dextrose. In addition, babies were allowed breast⁄ formula feed as they were taking before inclusion in the treatment of indirect hyperbilirubinemia in neonates, decreasing the need for exchange transfusion and decreasing duration of stay in NICU.
This study included 48 full-term infants with indirect non hemolytic neonatal jaundice. They were controlled from (NICU) at Menoufia university hospitals. Neonates were divided into 2 groups.: group 1: 24 neonates on breastfeeding and extra i.v. fluids half of their daily maintenance requirement for 8-h period and a phototherapy allowance of 20 ml ⁄ kg ⁄ day for 8 h. while group 2: 24 neonates feeding only with oral feeding(breast milk and formula)without intravenous fluids.
Full history taking and complete clinical examination were done. In our study, we found that receiving additional IV fluid supplementation was given for a period of 8 h. The volume of IV fluid supplementation included half of their daily maintenance requirement for 8-h period and a phototherapy allowance of 20 ml ⁄ kg ⁄ day for 8 h. In addition, babies were allowed breast⁄ formula feed as they were taking before inclusion starting treatment has a significant decrease in the level of total serum bilirubin in group 1 at different time points 24 hours , 48 hours ,72 hours and 96 hours of admission” P value 0.001 “ rather than group 2 .
Regarding patients remaining on phototherapy at each time point from the studied groups throughout the study, no patients were discharged and remained on phototherapy till 72 hours time point. Then, there was a significant difference at 96 hours time points in which (20 patients 83% from group1 discharged compared to no patients 0% discharged from group 2 (p=0.000).